Neuroblastoma: Experience from National University Health System, Singapore (1987-2008)

Singapore Medical Journal

Volumn 53, Issue 1, 2012, Pages 19-25

  Tan, C ^a   Sabai, S M ^b   Tin, A S ^c   Quah, T C ^d   Aung, L ^e  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c Singapore Health Services   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^e KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

Neuroblastoma; Singapore; Survival; Treatment

Indexed keywords

(3 IODOBENZYL) GUANIDINE I 131; BUSULFAN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; ISOTRETINOIN; MELPHALAN; TECHNETIUM 99M; UNCLASSIFIED DRUG; VINCRISTINE;

ABDOMINAL TUMOR; ADOLESCENT; ADRENAL TUMOR; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE SCINTISCANNING; CANCER STAGING; CHEMOTHERAPY; CHILD; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; MALE; MEDIASTINUM TUMOR; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SPINAL CORD TUMOR; SURVIVAL RATE;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; SINGAPORE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855846933     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Brodeur GM, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, 5th edn. Philadelphia: Lippincott Williams & Wilkins, 2006; 933-70.
2. Spix C, Pastore G, Sankila R, Stiller CA, Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42:2081-91.
3. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995; 75:2186-95.
4. Tan AM, Christina Ha. First Report of the Singapore Childhood Cancer Registry 1997-2005. Health Promotion Board Singapore: Singapore Childhood Cancer Registry. Available at: www.hpb.gov.sg/hpb/default. asp?pg_id=1631. Accessed April 19, 2011.
5. Kushner BH. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med 2004; 45:1172-88.
6. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999; 86:364-72.
7. Evans AE, D'Angio GJ, Propert K, Anderson J, Hann HW. Prognostic factors in neuroblastoma. Cancer 1987; 59:1853-9.
8. Perez CA, Matthay KK, Atkinson JB, et al. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer study group. J Clin Oncol 2000; 18:18-26.
9. De Bernardi B, Nicholas B, Boni L, et al. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. J Clin Oncol 2003; 21:1592-1601.
10. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 1993; 11:1466-77.
11. Tweddle DA, Pinkerton CR, Lewis IJ, et al. OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age. Med Pediatr Oncol 2001; 36: 239-42.
12. Kushner BH, Kramer K, LaQuaglia MP, et al. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. J Clin Oncol 2004; 22:4888-92.
13. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341:1165-73.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
15. Stiller CA, Parkin DM. International variations in the incidence of neuroblastoma. Int J Cancer 1992; 52:538-43.
16. Haupt R, Garaventa A, Gambini C, et al. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry. J Clin Oncol 2010; 28:2331-8.
17. Stram DO, Matthay KK, O'Leary M, et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol 1996; 14:2417-26.
18. Kushner BH, Cheung NK. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 1989; 73:1936-41.
19. Cheung NK, Guo HF, Heller G, Cheung IY. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma. Clin Cancer Res 2000; 6:2653-60.
20. Kushner BH, Kramer K, Cheung NK. Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma. J Clin Oncol 2001; 19:4189-94.
21. Kaneko M, Tsuchida Y, Uchino J, et al. Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma. J Pediatr Hematol Oncol 1999; 21:190-7.
22. Ng SM, Abdullah WA, Lin HP, Chan LL. Presenting features and treatment outcome of 78 Malaysian children with neuroblastoma. Southeast Asian J Trop Med Public Health 1999; 30:149-53.
23. Bansal D, Marwaha RK, Trehan A, Rao KL, Gupta V. Profile and outcome of neuroblastoma with conventional chemotherapy in children older than one year: a 15-years experience. Indian Pediatr 2008; 45:135-9.
24. Candito M, Thyss A, Albertini M, et al. Methylated catecholamine metabolites for diagnosis of neuroblastoma. Med Pediatr Oncol 1992; 20:215-20.
25. Bowen KA, Chung DH. Recent advances in neuroblastoma. Curr Opin Pediatr 2009; 21:350-6.